PATENT CLAIM ANALYSIS

Application Number: 16239529
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "449000"]

Abstract:
Disclosed herein are methods for treating and inhibiting the recurrence of bladder cancer by local administration of compositions comprising taxane particles such as docetaxel particles. Administration methods include intratumoral injection, direct injection into surgical tumor resection sites, and intravesical instillation.

Claim (Index 3):
The method of  claim 1 , wherein the periodic interval is about a week, about 2 weeks, about 3 weeks, about a month, about 2 months, or about 3 months.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.18919
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16007095', '16136502', '14868148', '16046812', '15625177']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7042929594889015
- 35 USC 102 Novelty (BERT): 0.5461420888973693
- Combined Prediction Score: 0.6884778724297482
- Mean Citation Score: 285.956902
- Max Citation Score: 336.6340600000001
- Similarity Product: 204.22426765331508

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test